Detection and identification of oxidized insulin-like growth factor-binding proteins and receptors in patients with colorectal carcinoma.
Colorectal cancer (CRC) is one of the most prevalent cancers worldwide and also the one with the highest mortality rate. Tumor growth is assisted by various growth factors, and insulin-like growth factors (IGFs) are among the most important. A majority of the IGFs are bound to IGF-binding proteins (IGFBPs) and their release is dependent on the rate of IGFBP proteolysis. The action of free IGFs is exerted and controlled by binding to cell membrane receptors (IGF-Rs). The objective of this work was to connect two determinants of the CRC pathology: oxidation as a process that underlies tumor development and the members of the IGF system that control it. Carbonyl groups (CO) on IGFBP-2, IGFBP-3, IGF-1R, and IGF-2R were determined in samples obtained from patients with CRC, and IGF-binding properties of these proteins were analyzed. According to our results, IGFBP-2 and IGFBP-3 in serum had increased content of CO groups due to CRC. Oxidation of IGFBP-2 increased its affinity for IGF molecules, whereas oxidation of IGFBP-3 reduced it. As for receptors, only intact CO-IGF-2R was detected on solubilized colon membranes, whereas CO-IGF-1R was degraded into fragments. Oxidative changes in the IGF axis may be regarded as part of the mechanism of its action. IGFs bound to IGFBP-3 remain in the circulation, whereas those bound to IGFBP-2 freely reach target tissues. Therefore, oxidation supports IGF distribution toward tissues and, consequently, promotes tumor growth.
Institute for the Application of Nuclear Energy, University of Belgrade, 11080 Belgrade, Serbia. Electronic address: olgica@inep.co.rs.
Olgica
O
Nedić
Institute for the Application of Nuclear Energy, University of Belgrade, 11080 Belgrade, Serbia.
Dragana
D
Robajac
Institute for the Application of Nuclear Energy, University of Belgrade, 11080 Belgrade, Serbia.
Miloš
M
Šunderić
Institute for the Application of Nuclear Energy, University of Belgrade, 11080 Belgrade, Serbia.
Goran
G
Miljuš
Clinical Medical Center "Bežanijska Kosa," Belgrade, Serbia.
Blagoje
B
Đukanović
Clinical Medical Center "Bežanijska Kosa," Belgrade, Serbia.
Vesna
V
Malenković
D015179:Colorectal Neoplasms / Q000473:pathology*; D006801:Humans; D018971:Insulin-Like Growth Factor Binding Protein 2 / Q000097:blood / Q000378:metabolism*; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000097:blood / Q000378:metabolism*; D010084:Oxidation-Reduction; D011485:Protein Binding; D017526:Receptor, IGF Type 1 / Q000378:metabolism; D017527:Receptor, IGF Type 2 / Q000378:metabolism; D013002:Somatomedins / Q000378:metabolism*
C577903:IGFBP2 protein, human; C515497:IGFBP3 protein, human; D018971:Insulin-Like Growth Factor Binding Protein 2; D018972:Insulin-Like Growth Factor Binding Protein 3; D017527:Receptor, IGF Type 2; D013002:Somatomedins; D017526:Receptor, IGF Type 1
CRC; Carbonylation; Colorectal cancer; Free radicals; IGF; IGF receptor; IGF-R; IGF-binding protein; IGFBP; Insulin-like growth factors; colorectal carcinoma; insulin-like growth factor